| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.300 | Biomarker | disease | CTD_human | Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patients. | 27720938 | 2016 | ||||
|
0.300 | Biomarker | disease | CTD_human | Intermittent chemotherapy and erlotinib for nonsmokers or light smokers with advanced adenocarcinoma of the lung: a phase II clinical trial. | 21541241 | 2011 | ||||
|
0.300 | Biomarker | disease | CTD_human | MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib. | 22042947 | 2011 | ||||
|
0.300 | Biomarker | disease | CTD_human | Co-activation of epidermal growth factor receptor and c-MET defines a distinct subset of lung adenocarcinomas. | 20934974 | 2010 | ||||
|
0.300 | Biomarker | disease | CTD_human | Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines. | 2523869 | 1989 |